Australian Technical Advisory Group on Immunisation (ATAGI)

Australian Technical Advisory Group on Immunisation (ATAGI) meeting agenda.

Page last updated: 01 March 2016

Australian Technical Advisory Group on Immunisation (ATAGI) 59th Meeting - February 2016

Agenda – Day 1

Item Purpose
1. Welcome and Apologies and general committee business
1.2 Conflict of Interest and Confidentiality Information
1.3 Actions arising from previous meeting Information
1.4 Out of session items including correspondence Information
2. Pneumococcal vaccine
2.1 Endorse advice on pneumococcal vaccine for a submission to the PBAC Endorse
2.2 Review of evidence supporting updating of ATAGI recommendations on pneumococcal vaccinations Discuss
3. Influenza vaccine
3.1 ATAGI advice on QIV vaccines for submission to the PBAC Endorse
3.2 Modelling studies for assessing the disease burden of influenza and impact on immunisation strategies Discuss
3.3 Draft Influenza Chapter for the Australian Immunisation Handbook 2016 Update and the 2016 Provider and Consumer ATAGI Statements on Administration of influenza vaccine Endorse
4. Pertussis vaccine
4.1 Advice on providing pertussis vaccine to pregnant women in the National Immunisation Program Information
5. Report from Pharmaceutical Benefits Advisory Committee
5.1 Report on previous and upcoming PBAC meetings
5.2 PBAC Guidelines Review – Vaccine Products
Discuss
Meeting closed

Agenda – Day 2

Agenda item
6. Recap of day one
6.1 Pneumococcal PBAC advice, Influenza Chapter of Handbook and Influenza Statements Endorse
7. Australian Immunisation Handbook Update
7.1 Consultation Report of Chapter 4.23 Yellow Fever Endorse
7.2 Changes for inclusion in the Australian Immunisation Handbook 2016 Update Endorse
7.3 Australian Immunisation Handbook 2017 advice for pneumococcal vaccinations Discuss
7.4 Terms of Reference for the Australian Immunisation Handbook Working Party Endorse
8. Department / Committees updates
8.1 Department of Health update Information
8.2 TGA/ACSOV Update Information
8.3 Communicable Diseases Network Australia Report and Epidemiology of Vaccine Preventable Diseases Information
9. Report from the Chair and Deputy Chair
9.1 Strategic Vision for ATAGI Discuss
9.2 Other ATAGI WP Business and Review of membership of ATAGI Working Parties and any gaps Endorse
9.3 Report on Asian Pacific Vaccinology meeting Information
9.4 ATAGI Work plan Information
10. NCIRS Report Information
11. The role of ATAGI in the regional and global collaboration between NITAGs: application to NITAG performance evaluation Presentation
Meeting closed

Endorse = a decision is to be made at this meeting
Discuss = a decision is to be made at a future meeting or out of session
Information = no decision points at this stage